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ARTICLE
Recruited macrophages that colonize the post-
inflammatory peritoneal niche convert into
functionally divergent resident cells
P. A. Louwe 1, L. Badiola Gomez 1, H. Webster2, G. Perona-Wright 2, C. C. Bain 1, S. J. Forbes 3 &
S. J. Jenkins 1✉
Inflammation generally leads to recruitment of monocyte-derived macrophages. What regulates
the fate of these cells and to what extent they can assume the identity and function of resident
macrophages is unclear. Here, we show that macrophages elicited into the peritoneal cavity
during mild inflammation persist long-term but are retained in an immature transitory state
of differentiation due to the presence of enduring resident macrophages. By contrast, severe
inflammation results in ablation of resident macrophages and a protracted phase wherein the
cavity is incapable of sustaining a resident phenotype, yet ultimately elicited cells acquire a
mature resident identity. These macrophages also have transcriptionally and functionally
divergent features that result from inflammation-driven alterations to the peritoneal cavity
micro-environment and, to a lesser extent, effects of origin and time-of-residency. Hence, rather
than being predetermined, the fate of inflammation-elicited peritoneal macrophages seems to be
regulated by the environment.
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Inflammation alters the composition and function of the tissuemacrophage compartment, typically leading to substantialrecruitment of monocytes from the blood and activation or
even loss of the tissue-resident cells1. While these early cellular
processes have been well-characterized across various tissues and
models of inflammation, it remains unclear how homeostasis
within the macrophage compartment is reinstated post inflam-
mation and consequently what long-term effects inflammation
may have on tissue macrophage function.
In the steady-state, resident macrophages across tissues share
expression of core lineage-related genes upon which a tissue-
specific transcriptional, epigenetic, and functional identity is
overlaid2–5. These unique molecular identities are largely estab-
lished upon exposure to tissue-specific environmental signals that
in turn drive expression of tissue-specific transcription factors.
Tissue resident macrophages also have diverse developmental
origins6,7 with many tissues containing self-renewing populations
largely seeded during embryogenesis and short-lived bone mar-
row (BM)-derived populations that seemingly inhabit distinct
anatomical regions8,9. However, in the absence of embryonically
seeded macrophages, circulating monocytes appear able to give
rise to long-lived and transcriptionally and functionally normal
resident cells10–14, suggesting origin may not be a key determi-
nant of macrophage identity per se, but rather tissue-specific
anatomically restricted signals and cell interactions constitute a
niche that controls macrophage longevity and gene expression.
While a small number of seemingly ontogeny-related transcrip-
tional differences may distinguish embryonic and monocyte-
derived resident macrophages present within the same niche12,14,
limited evidence suggests that even these may be gradually
reprogrammed over time13,15. Based on these observations, it has
been proposed that competition for signals and cell-to-cell
interactions that drive survival and proliferation of macro-
phages and expression of tissue-specific transcription factors
dictates the balance between incumbent resident macrophages
and infiltrating monocytes16,17.
Macrophages in the peritoneal cavity regulate peritoneal
B1 cells15,18 and provide immune surveillance of the cavity19 and
neighboring tissues20 but they are also implicated in many
pathologies, including endometriosis, post-surgical adhesions,
pancreatitis, and metastatic cancer19. The peritoneal cavity con-
tains two populations of resident macrophages: an abundant
population of so-called “large” peritoneal macrophages (LPM)
that are embryonically seeded and long-lived, and a rarer popu-
lation of short-lived MHCII+ monocyte-derived cells termed
small peritoneal macrophages (SPM)21. The transcriptional
identity of LPM is dependent upon the transcription factors
GATA65,22,23 and CEBPβ24 while SPM depend upon IRF425.
Expression of GATA6 by LPM is driven primarily by omentum-
derived retinoic acid5 at least in part via retinoid X receptors
alpha and beta (RXRα/β)26. Despite initially having an embryonic
origin, the LPM population is gradually replaced by monocyte-
derived cells with age, a process that occurs more rapidly in
males21. Thus, differential rates of replenishment alters the time-
of-residency of each macrophage, which leads to differences in
phenotype and function of LPM between the sexes and with
age15,21. Indeed, single-cell RNA-sequencing of peritoneal mac-
rophages has revealed LPM comprise multiple transcriptionally
distinct subsets15,27 that, at least in females, appear to represent
states associated with different times-of-residency15. However,
while tissue-resident macrophages in solid organs are envisaged
to have a static architectural niche comprising stable cell
interactions16,28 as delineated in several tissues29–31, peritoneal
macrophages “float” in a fluidic environment32 implying more
complex interactions control their maintenance, identity and sub-
specialization.
Monocyte-derived macrophages recruited during inflammation
typically exhibit distinct transcriptional, functional and pheno-
typic signatures to resident cells, even in tissue sites where resi-
dent cells are ordinarily replenished by monocytes33,34. However,
it’s unclear whether inflammatory macrophages are fully capable
of reprogramming to become resident macrophages and hence if
their fate is predominantly regulated by access to appropriate
niche signals or rather predetermined during their initial differ-
entiation. Macrophages recruited to the alveolar space following
influenza infection or bleomycin-induced lung damage persist for
many months35,36, but retain significant transcriptional differ-
ences to enduring resident cells. Notably, established resident
macrophages exhibit a relatively poor ability to engraft and
reprogram upon adoptive transfer into an ectopic tissue site4,14,
suggesting that differentiation of macrophages may lead to sub-
stantial loss in plasticity. Irrespective, if reprogramming of
inflammatory macrophages also has an element of time-depen-
dence, their persistence would be predicted to lead to prolonged
alteration in the functional capacity of the tissue macrophage
compartment.
In the peritoneal cavity, sterile inflammation can cause sub-
stantial contraction in number of LPM through cell death or loss
in fibrin clots32,37 but the extent of this loss appears dependent on
stimulus and severity of inflammation37,38. While remaining
LPM can subsequently proliferate during the resolution phase39,
peritoneal inflammation40,41, including that caused by abdominal
surgery15 can lead to at least partial replacement of the long-lived
LPM population from the BM, with the degree of replacement
seeming to correlate with the extent of the preceding loss of
incumbent cells37. The functional implications of displacement of
the resident population remains unclear.
Here, we study the peritoneal cavity to investigate what reg-
ulates the fate of inflammatory macrophages following sterile
inflammation. Using adoptive transfer to unequivocally track
inflammatory macrophages and identify the degree to which the
environment controls the fate of these cells, we demonstrate that
macrophages infiltrating the cavity after mild inflammation per-
sist long-term, but that competition with incumbent resident
macrophages inhibits effective acquisition of a mature resident
phenotype. Consistent with this competition model, severe
inflammation, which causes ablation of incumbent resident
macrophages, results in conversion of inflammatory macrophages
to mature resident cells. We therefore identify the existence of a
biochemical niche for resident peritoneal macrophages. Compe-
tition for this niche controls the capacity of monocyte-derived
cells to undergo conversion to mature resident macrophages and
a failure to compete retains them in a highly proliferative and
immunoregulatory state.
Results
Inflammatory macrophages persist after mild peritoneal
inflammation. To investigate what regulates the fate and phe-
notype of inflammatory and resident macrophages following
resolution of sterile peritoneal inflammation, we used a well-
characterized model of intraperitoneal injection with low-dose
zymosan A (10 μg/mouse), in which both populations remain
present following resolution of the neutrophilic phase38,39,42.
First, to definitively delineate incumbent resident cells from
inflammatory macrophages recruited during the acute phase of
inflammation, we utilized an established method of injecting
fluorescent PKH26-PCL dye intraperitoneally 24 h before zymo-
san to exclusively label peritoneal phagocytes present prior to
inflammation40. Uptake of PKH26-PCL dye was largely restricted
to all resident LPM and most SPM (Supplementary Fig. 1a),
identified as F4/80Hi or F4/80Lo CD226+ cells, respectively25,42,
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and no free dye remained 24 h later (Supplementary Fig. 1b, c).
Subsequent injection of low-dose zymosan-induced dis-
appearance of dye-labeled (DyeHi) F4/80Hi resident macrophages
and influx of dye-negative (DyeLo) Ly6c+ monocytes and neu-
trophils within 4 h. By day 3, neutrophils were largely cleared and
remaining DyeLo infiltrating cells now exhibited a predominantly
F4/80Int Ly6cLo/Int phenotype consistent with inflammatory
macrophages33,38 and dyeHi F4/80Hi resident macrophages had
partially recovered in number (Fig. 1a, b), consistent with their
reported repopulation by self-renewal in this model39. Finally, to
validate our dye-based tracking system, we assessed dye-labeling
in tissue-protected BM chimeric mice, which allow recruited and
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resident cells to be determined definitively21. This confirmed that
DyeLo F4/80Int macrophages present in the peritoneal cavity at
day 3 were derived from recruited cells as evidenced by their
high levels of non-host chimerism, whereas DyeHi F4/80Hi cells
displayed low levels of chimerism, demonstrating their tissue
residency (Supplementary Fig. 1d). Moreover, DyeLo F4/80Int
had high levels of MHCII and virtually no expression of the
resident macrophage marker Tim4 (Supplementary Fig. 1e),
features known to differentiate inflammatory from resident
macrophages during resolution33,38. Thus, PKH26-PCL-
labeling faithfully delineated resident vs recruited macrophage
subsets and importantly, this system used a minimal number of
surface antibodies thereby circumventing potential confound-
ing effects of adoptive transfer of antibody-coated cells.
Next, we used adoptive transfer to unequivocally determine
the fate of these populations. Specifically, DyeHi F4/80Hi
resident macrophages (RMacZ10) and DyeLo F4/80Int inflam-
matory macrophages (IMacZ10) were FACS-purified from
C57BL/6 WT (CD45.2+) donor mice 3 days after injection of
low-dose zymosan (Fig. 1a) and transferred intraperitoneally
into separate congenic WT (CD45.1/2+) host animals. Reci-
pient mice had been pre-treated 3 days prior with an equivalent
dose of zymosan to ensure labeled cells were transferred into a
similar environment (Fig. 1c, native). Eight days post transfer,
transferred donor RMacZ10 and IMacZ10 exhibited a similar
degree of engraftment, defined as the number retrieved as a
proportion of those transferred, although this was somewhat
greater for RMacZ10 (Fig. 1d). Whereas transferred RMacZ10
remained predominantly MHCIILo, IMacZ10 remained largely
MHCIIHi and continued to express marginally less F4/80 such
that the two donor populations were identified with relative
accuracy using these markers (Fig. 1e). Critically, virtually all
transferred IMacZ10 expressed the LPM-specific transcription
factor GATA6 but at markedly lower levels than RMacZ10
(Fig. 1j). The host CD11b+ myeloid compartment also
contained a mixture of F4/80Int/Hi MHCIIHi GATA6+ and
F4/80Hi MHCIILo GATA6+ macrophages, consistent with persis-
tence of endogenous inflammatory and resident macrophages,
but also a minor fraction of F4/80LoMHCIIHiGATA6− cells (Fig. 1e
and Supplementary Fig. 2a) suggestive of newly generated
SPM and/or CD11b+ DCs. Hence, by combining dye-labeling
and adoptive transfer, we have developed a robust system to
identify and fate map tissue-resident and inflammatory
macrophages in the context of peritoneal inflammation
and reveal that distinct populations of MHCII− and MHCII+
peritoneal macrophages persist following zymosan-induced
peritoneal inflammation due to endurance of tissue-resident
macrophages established prior to inflammation and monocyte-
derived macrophages recruited at the onset of inflammation,
respectively.
Resident macrophages limit initial survival and phenotype of
IMacZ10. We next explored what regulates the short-term fate of
these cells. First, we transferred RMacZ10 and IMacZ10 into naïve-
recipient mice (Fig. 1c, naïve) to determine whether their survival
and phenotype is dictated primarily by the post inflammation
micro-environment. In this non-inflamed environment both
donor populations persisted equally (Fig. 1f), with a level of
engraftment akin to that observed for RMacZ10 transferred to
inflamed mice (Fig. 1d). Despite this, IMacZ10 remained MHCIIHi
(Fig. 1g) and expressed intermediate levels of GATA6 (Fig. 1k),
suggesting this phenotype was not a product of the post-
inflammatory micro-environment.
Next to determine if competition with resident macrophages
regulates survival and phenotype of IMacZ10, we pre-treated
recipient mice 7 days prior to transfer with clodronate-loaded
liposomes (Fig. 1c, depleted). This regime caused rapid and
prolonged loss of recipient F4/80Hi LPM, with the cavity being
essentially devoid of these cells at the point of adoptive transfer at
day 7 (Supplementary Fig. 2b). In the absence of endogenous
resident macrophages, engraftment efficiency of IMacZ10 was
approximately 250%, indicating these cells have the ability to
expand to fill the empty niche (Fig. 1h). Furthermore, nearly 50%
of IMacZ10 adopted a more resident-like MHCIILo phenotype
(Fig. 1i) but failed to acquire similar levels of GATA6 as RMacZ10
within this period (Fig. 1l). Surprisingly, although RMacZ10 also
persisted better in the depleted environment, with an engraftment
efficiency nearer 100%, they were unable to expand to the same
degree as IMacZ10 (Fig. 1h). Notably, host macrophages also
repopulated the cavity during this period, yet they largely
exhibited an MHCIIHi phenotype (Fig. 1i) resembling that of
IMacZ10 in their native inflamed environment, suggesting these
cells likely derive from Ly6C+ monocytes recruited to the cavity
post-depletion (Supplementary Fig. 2b). We also found that
irrespective of environment, nearly all IMacZ10 expressed the
GATA6-independent LPM marker CD1025 yet few expressed
Tim4 (Supplementary Fig. 2c). Altogether, these data suggest that
while IMacZ10 persist through the early phases of resolution, their
survival and conversion to MHCIILo cells is largely regulated by
the presence of competing resident macrophages.
Fig. 1 Competition mediates inflammatory macrophage phenotype early post resolution. a F4/80HI PKH26-PCLHi resident macrophages, PKH26-PCLLo
Ly6c+ monocytes and PKH26-PCLLo F4/80Int inflammatory macrophages in the naïve peritoneal cavity, 4 h and 3 days post 10 μg zymosan. b Number of
RMac, Monocytes, IMac, and Neutrophils the naïve peritoneal cavity (n= 8), 4 h post zymosan (n= 9) and 3 days post zymosan (n= 9). *p < 0.05,
****p < 0.0001, one-way ANOVA with Tukey’s multiple comparisons test. c Experimental scheme for transfer of RMacZ10 (blue) or IMacZ10 (orange) into
mirroring inflamed (native), naïve or depleted recipient mice. d Engraftment efficiency of RMacZ10 (n= 6) and IMacZ10 (n= 8) 8 days after transfer into
inflamed recipients. p= 0.029(*), Mann–Whitney test. e F4/80 and MHCII expression by RMacZ10 (n= 6), IMacZ10 (n= 8) or host (n= 14) cells 8 days
post transfer. Each comparison p < 0.0001(****), determined by two-way ANOVA and post hoc Tukey test. f Engraftment efficiency of RMacZ10 (n= 7)
and IMacZ10 (n= 7) 8 days after transfer into naïve recipients. Significance determined using Mann–Whitney test. g F4/80 and MHCII expression by
RMacZ10 n= 7), IMacZ10 (n= 7), or host (n= 14) cells 8 days after transfer. Each comparison p < 0.0001(****), two-way ANOVA and post hoc Tukey test.
h Engraftment efficiency of RMacZ10 (n= 8) and IMacZ10 (n= 6) 8 days after transfer into clodronate-depleted recipients. p= 0.008(**), Mann–Whitney
test. i F4/80 and MHCII expression by RMacZ10 (n= 8), IMacZ10 (n= 6), or host (n= 14) cells 8 days after transfer. Each comparison p < 0.0001(****),
two-way ANOVA and post hoc Tukey test. j Proportion of RMacZ10(n= 4), IMacZ10 (n= 5) that are GATA6+ and MFI of GATA6 expression 8 days after
transfer into inflamed recipients. p < 0.0001 (****), student’s t-test. k Proportion of RMacZ10 (n= 5) and IMacZ10 (n= 5) that are GATA6+ and MFI of
GATA6 expression 8 days after transfer into naïve recipients. p < 0.0001 (****), student’s t-test. l Proportion of RMacZ10 (n= 6) and IMacZ10 (n= 5) that
are GATA6+ and MFI of GATA6 expression 8 days after transfer into clodronate-depleted recipients. p= 0.023(*), student’s t-test. Experiments are
presented as mean ± standard deviation. Each symbol represents an individual animal. Data were pooled from at least two independent experiments. Host
cells represented by squares or circles are from recipients of RMacZ10 or IMacZ10, respectively.
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GATA6 expression by LPM is largely induced by retinoic acid
from omental and peritoneal stromal cells whereas the omentum
produces additional factors that can drive retinoic acid-
independent features of LPM5,43. We therefore cultured perito-
neal cells collected 11 days post zymosan with all trans retinoic
acid (ATRA) or omentum culture supernatant (Om factors) for
24 h to determine whether MHCII expression by inflammatory
macrophages is responsive to retinoic acid or other omental
factors. As CD102 and Tim4 did not appear to be altered in any
of the in vivo experiments we used these to identify resident
(CD102+/Tim4+) and inflammatory (CD102+Tim4−) macro-
phages post culture. Indeed, post culture expression of these
surface markers remained unchanged between treatments
(Fig. 2a). Culture with ATRA led to increased expression of the
GATA6 responsive marker F4/805 by CD102+/Tim4+ resident
and CD102+Tim4−inflammatory macrophages but not down-
regulation of their MHCII expression. In contrast, culture
with omental supernatant led to downregulation of MHCII by
CD102+Tim4−inflammatory macrophages (Fig. 2b). Hence, the
presence of competing resident macrophages may limit the
differentiation of inflammatory macrophages to a MHCIILo
resident phenotype by restricting availability of retinoic acid-
independent signals from the omental niche.
Subsequently, to ascertain whether access to retinoic acid was the
limiting factor in the degree of GATA6 expression by IMacZ10
in vivo, we administered ATRA or oil vehicle every other day
following adoptive transfer of RMacZ10 or IMacZ10 into inflamed
recipient mice (Supplementary Fig. 2d). Unfortunately, injection of
the oil vehicle led to complete replacement of the macrophage
compartment by host Ly6C+ monocytes and F4/80lo macrophages
as no donor cells were detected at day 8 in any group
(Supplementary Fig. 2e). However, while only a minor fraction of
host F4/80lo macrophages expressed high levels of GATA6,
treatment with ATRA increased this almost 4-fold (Supplementary
Fig. 2f, g), suggesting the availability of retinoic acid limits GATA6
expression by inflammatory macrophages.
IMacZ10 retain intrinsic and environment-driven features
long-term. To investigate whether IMacZ10 can persist long-term
and assimilate into the resident LPM compartment, we continued
to track these and the prevailing RMacZ10 following transfer into
native inflamed cavities versus macrophage-depleted cavities and
assessed their phenotype after 8 weeks. To understand whether
inflammation changed the behavior and long-term fate of
RMacZ10, we included F4/80Hi DyeHi LPM from naïve donors
(RMac) transferred into naïve mice or macrophage-depleted
animals for comparison (Fig. 3a). Notably, only 60% of the
transferred RMacZ10 retained PKH26-PCL-labeling by this time
while some recipient cells had acquired dye (Supplementary
Fig. 3a) confirming the need for adoptive transfer to accurately
discriminate these cells. In these experiments, a similar propor-
tion of transferred IMacZ10 persisted in their native environment
to both RMacZ10 and RMac (Fig. 3b, left). However, retrospective
pooling of all data generated from this time-point throughout our
study (Figs. 3b with 5b) revealed an overall pattern that was
similar to day 8, whereby IMacZ10 persisted marginally less well
than their RMacZ10 counterparts (Supplementary Fig. 3b).
Indeed, the overall similarity in survival of donor IMacZ10 and
RMacZ10 between day 8 (Fig. 1d) and week 8 (Fig. 3b) post
transfer suggests little loss of either population occurred in
this time and demonstrates that macrophages elicited by an
inflammatory agent become long-lived resident macrophages.
Furthermore, the comparable survival of both IMacZ10 and
RMacZ10 to RMac in naïve mice suggests that as early as day 3
post zymosan injection the homeostatic mechanisms regulating
longevity/autonomy of peritoneal macrophages are reinstated.
Following transfer into depleted recipients, IMacZ10 again
expanded significantly in number whereas RMacZ10 did not
(Fig. 3b, right). Likewise, the similarity in persistence of engrafted
IMacZ10 and RMacZ10 between day 8 (Fig. 1h) and week 8 post
transfer (Fig. 3b) suggests that the resident peritoneal macro-
phage pool also quickly re-establishes following depletion and
resumes self-maintenance irrespective of origin.
Importantly, even after 8 weeks in their native environment
IMacZ10 exhibited lower expression of GATA6, marginally less
F4/80, and a higher proportion of MHCII+ cells than either
RMac population (Fig. 3d, e and Supplementary Fig. 3d). In
contrast, prior removal of competing endogenous cells through
administration of clodronate liposomes allowed transferred
IMacZ10 to fully acquire the MHCIILoGATA6Hi phenotype of
RMacZ10 within 8 weeks (Fig. 3d, e and Supplementary Fig. 3d).
To investigate the wider transcriptional integration of IMacZ10
within the resident LPM compartment, we sorted the 3 donor
populations from both native and depleted environments at
8 weeks post transfer and investigated gene expression using the
NanoString nCounter mouse myeloid panel. This analysis
revealed that in their native environment IMacZ10 remained
highly transcriptionally distinct from RMacZ10, with 78 of the 372
detected genes being differentially expressed (Supplementary
Data 1, Fig. 3f, Supplementary Fig. 3e), whereas no detectable
differences were apparent between RMac and RMac10 (Supple-
mentary Data 2). Of the 13 genes included in the panel that are
unique to peritoneal LPM5,43, 11 were differentially expressed
between IMacZ10 and RMacZ10 (Supplementary Fig. 3f) including
Fig. 2 Inflammatory macrophages are responsive to niche factors in vitro. a Expression of CD102 and Tim4 by cultured cells after 24 h culture with
indicated treatment. b Proportion of macrophage subsets that express MHCII and F4/80 MFI after 24 h culture with control medium (n= 8), Omentum
factor containing medium (n= 4) or ATRA containing medium (n= 8). MHCII+: p= 0.0046 (**), F4/80 MFI: p= 0.0028 (**), p= 0.032 (*), determined
by one-way ANOVA and Dunnet’s multiple comparisons test for each subset individually, followed by Bonferroni adjustment. Data was pooled from 2
independent experiments and are presented as mean ± standard deviation. For each treatment group a symbol represents a culture well derived from an
individual mouse.
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Gata6. In contrast, Cebpb, which encodes the transcription factor
CEBPβ upon which LPM are also dependent24, was expressed
equally by IMacZ10 (Supplementary Data 1). A quarter of the
genes differentially expressed between IMacZ10 and RMacZ10
overlapped with those regulated by GATA6 in LPM5,22,23,
including Adgre1, which encodes F4/80, and consequently the
gene signature of IMacZ10 largely aligned with that of Gata6-
deficient LPM5,22,23 (Supplementary Fig. 3g). As GATA6
expression by LPM is regulated by retinoic acid through RXRα
and RXRβ26, we also assessed overlap with other genes regulated
by RXRAB independent of GATA6 (Supplementary Fig. 3g) and
found that a further fifth of the genes that differentiated IMacZ10
from RMacZ10 to potentially arise from this pathway.
Furthermore, comparison with our published single-cell
RNAseq analysis15 of LPM revealed that genes expressed more
highly in IMacZ10 overlapped exclusively with those expressed
more highly by LPM of recent monocyte origin in naïve female
mice (Cluster 3 and 4, e.g. Apoe, Retnla, and genes related to
MHCII presentation), whereas genes expressed more highly in
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highly by the most long-lived LPM (Cluster 5, e.g. Timd4, Cxcl13,
and Gata6) (Fig. 3f). Moreover, re-analysis of our single-cell
RNA-seq dataset of LPM15 revealed that cluster markers that
define monocyte-derived LPM overlapped markedly and exclu-
sively with genes expressed more highly by Gata6-deficient or
RXRAB-deficient macrophages5,22,23, whereas cluster markers of
established LPM overlapped substantially and exclusively with
genes expressed more highly by Gata6-sufficient or RXRAB-
sufficient LPM (Supplementary Fig. 3h).
Hence, these data suggest that differences in retinoic acid
signaling, either directly or via GATA6, between established
resident macrophages and incoming monocyte-derived macro-
phages controls a significant proportion of the genes differentially
expressed between these populations in steady-state and post
inflammation. Critically, gene expression profiling suggested that
IMacZ10 and RMacZ10 became transcriptionally more similar
after transfer into depleted recipients, with the number of
differentially expressed genes decreasing from 78 to 8 (Fig. 3f and
Supplementary Data 3). Notably, differences in Gata6 and almost
all the potentially GATA6-regulated genes were lost (Supple-
mentary Fig. 3i), as were differences in most other genes that
defined clusters identified in steady-state15, including Cxcl13 and
MHCII-related genes. Unsurprisingly, RMac and RMacZ10
remained transcriptionally indistinct in the macrophage-deplete
environment (Supplementary Data 4). Importantly, gene-ranking
analysis indicated that neither RMac nor RMacZ10 altered their
transcriptional identity following transfer into depleted recipients
(Supplementary Fig. 3j and Supplementary Data 5). This
demonstrates that the transcriptional coalescence of IMacZ10
and RMacZ10 that occurs upon transfer into the macrophage-
depleted environment is largely caused by transformation of
IMacZ10 into RMacZ10 rather than the transformation of
RMacZ10 into IMacZ10. Furthermore, these data suggest the
majority of transcriptional differences between IMacZ10 and
RMacZ10 are determined by the post-inflammatory environment
or competition with incumbent resident macrophages for access
to niche signals, whereas a smaller number of differentially
expressed genes may represent cell-intrinsic features related to
origin. Specifically, enduring resident macrophages seemingly
prevent IMacZ10 transition to a mature GATA6hi phenotype, thus
retaining them in a transcriptional state associated with steady-
state monocyte-derived LPM.
Flow-cytometric analysis confirmed that within the native post-
inflammatory environment, IMacZ10 expressed higher levels of
Sema4a, CD62L, and CCR5 and but largely failed to acquire
expression of Tim4 (Fig. 3g, left), consistent with the differential
expression of Sema4a, Sell (encoding for CD62L), Ccr5, and Timd4
detected by NanoString. Similarly, IMacZ10 in the depleted
environment retained equivalently high levels of Sema4a and
CD62L, and low levels of Tim4 expression (Fig. 3g, right),
consistent with these being cell-intrinsic rather than environment-
dependent features of IMacZ10 (Fig. 3f). In line with an expression
pattern predominantly dictated by environmental cues, we found
that IMacZ10 expressed more variable and on the whole lower levels
of CCR5 in the macrophage-depleted environment (Fig. 3g, right).
We extended this analysis to include surface markers that define
newly monocyte-derived (Folate receptor β (FRβ)) and long-lived
resident peritoneal macrophages (CD209b and V-set immunoglo-
bulin domain-containing 4 (VSIG4))15. IMacZ10 failed to acquire
equivalent expression of CD209b or VSIG4 to either RMacZ10
population irrespective of environment, whereas they exhibited
comparatively high levels of FRβ in the native environment that,
like CCR5, was lost in macrophage-depleted recipients, suggesting
downregulation by environmental cues (Supplementary Fig. 3k).
Finally, we determined whether reprogramming of IMacZ10 may
occur naturally over the lifespan following inflammation. Fate-
mapping for 5 months revealed continued persistence of IMacZ10,
RMacZ10 and RMac transferred into their native environments
(Fig. 3h), although only RMac appeared to survive as well as at
8 weeks (Fig. 3b). Within this time IMacZ10 had downregulated
MHCII to levels equivalent to RMacZ10, yet they continued to
express lower levels of GATA6 and retain higher proportions of
cells expressing Sema4a, CD62L, CCR5 (Fig. 3i, j) and FRβ
(Supplementary Fig. 3l). Despite this, fewer IMacZ10 expressed
CCR5 or FRβ than at 8 weeks (Figs. 3g “native” vs. 3i and
Supplementary Fig. 3k “native” vs. 3l), consistent with gradual
reprogramming of expression of these markers, whereas expression
of Sema4a and CD62L remained unchanged. Furthermore, IMacZ10
had acquired equivalent levels of VSIG4 to RMacZ10 by this time
but failed to upregulate expression of Tim4 and CD209b to levels
observed on the resident populations (Fig. 3i and Supplementary
Fig. 3l), despite the frequency of IMacZ10 expressing these markers
increasing compared to 8 weeks (Fig. 3g “native” vs. 3i and
Supplementary Fig. 3k “native” vs. 3l). Of note, the low frequency of
RMac and RMacZ10 that expressed CCR5 and FRβ by week 8 of
transfer was seemingly reduced even further by 5 months, while the
proportion that expressed Vsig4 and CD209b continued to rise
gradually (Fig. 3g “native” vs. 3i and Supplementary Fig. 3k “native”
vs. Supplementary Fig. 3l). These data are consistent with our
previous supposition that expression of Tim4, CD209b and VSIG4
Fig. 3 Long-lived colonizing inflammatory macrophages retain intrinsic and environment-dependent differences to RMac. a Experimental scheme for
transfer of RMac, RMacZ10 or IMacZ10 into naïve, inflamed or clodronate-depleted recipients. b Engraftment efficiency of RMac, RMacZ10 and IMacZ10
8 weeks after transfer into native (left; n= 13, n= 9, n= 9) or depleted recipients (right; n= 10, n= 10, n= 8) **p < 0.01, one-way ANOVA and Tukey’s
multiple comparisons test. c Expression of F4/80 and MHCII 8 weeks after transfer into native or clodronate-depleted recipients. d Proportion of RMac,
RMacZ10, and IMacZ10 that express MHCII 8 weeks after transfer into native (left; n= 13,11,11) or depleted recipients (right; 10, 10, 8). p= 0.00037 (***),
one-way ANOVA and Tukey’s multiple comparisons test. e GATA6 MFI 8 weeks after transfer of RMac, RMacZ10, or IMacZ10 into native (left; n= 12,11,11)
or depleted (right; n= 10,10,8) recipients. p < 0.0001(****), one-way ANOVA and Tukey’s multiple comparisons test. f Venn diagram indicating overlap
between genes differentially expressed between RMacZ10 and IMacZ10 (adj p-value < 0.05), 8 weeks after transfer into native (blue) or depleted (red)
recipients, and circus plot depicting differentially expressed genes that are cluster markers identified by Bain et al.15. gMarker expression by CD102+ RMac
(black), RMacZ10 (blue) and IMacZ10 (orange) 8 week after transfer into native (left; n= 7,6,6) or depleted recipients (right; n= 5, 5, 4). **p < 0.01, **p <
0.01 ***p < 0.001, one-way ANOVA and Dunnet’s multiple comparisons test for each marker, followed by Bonferroni adjustment. h Engraftment efficiency
of RMac, RMacZ10, and IMacZ10 22 weeks after transfer into native recipients (n= 4, 5, 5). *p < 0.05, one-way ANOVA and Tukey’s multiple comparisons
test. iMarker expression by CD102+ RMac (black), RMacZ10 (blue) and IMacZ10 (orange) 22 weeks after transfer into native (n= 4, 5, 5) recipients. **p <
0.01 ***p < 0.001, one-way ANOVA and Dunnet’s multiple comparisons test for each marker, followed by Bonferroni adjustment. j GATA6 MFI, 22 weeks
after transfer of RMac, RMacZ10, or IMacZ10 into native (n= 2, 3, 3) recipients. p= 0.019 (*), one-way ANOVA and Tukey’s multiple comparisons test.
Data are presented as mean ± standard deviation with each symbol representing an individual animal. Data were pooled from at least two independent
experiments, except for j, which is a single experiment. Host cells represented by squares or circles are recipients of RMacZ10 or IMacZ10, respectively.
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by LPM is regulated by time-of-residency and demonstrate this
remains so following mild inflammation. Hence, the distinct
phenotype of IMac-derived LPM appear to comprise: (1)
predetermined features seemingly retained over time and not
reprogrammed by niche signals (CD62L, Sema4a); (2) features that
fail to reprogram due to an inability to compete with RMacZ10 for
environmental cues but that are reprogrammed with time (MHCII,
GATA6, CCR5, FRβ); and (3) features related to time-of-residency
irrespective of competition with RMacZ10 (VSIG4, Tim4, CD209b).
Colonizing IMacZ10 are functionally akin to monocyte-derived
RMac. To determine whether colonizing inflammatory macro-
phages differ functionally and behaviorally to established resident
macrophages, we developed a gating strategy based on a Tim4+
Sema4a− (R1) and Tim4−Sema4a+ (R3) profile to identify the
majority of RMacZ10 and IMacZ10, respectively (Fig. 4a, b). Using
this approach, we were able to track the major long-term changes
in phenotype of the resident LPM pool triggered by inflammation
without need for dye-based fate-mapping (Supplementary
Fig. 4b). In addition, to determine whether IMac-derived LPM are
functionally similar to LPM of recent monocyte-origin recruited
during homeostasis, we confirmed that the Tim4−Sema4a+ gate
identified the majority of Tim4− MHCII+ LPM in naïve mice
(Supplementary Fig. 4c), which we previously validated to iden-
tify newly monocyte-derived LPM15.
Consistent with our previous observations showing that LPM
of recent monocyte-origin proliferate more than established LPM
during homeostasis21, the Sema4a+Tim4− fraction of LPM from
naïve mice (subsequently referred to as Mo-LPM and RM-LPM,
respectively) exhibited the highest level of proliferation, as
determined by Ki67 expression (Fig. 4c). Similarly, Sema4a+
Tim4− and Sema4− Tim4+ defined-populations found 8 weeks
post zymosan injection (subsequently referred to as MoZ10-LPM
and RMZ10-LPM, respectively) exhibited the same divergent
pattern in proliferative activity (Fig. 4c). Furthermore, re-analysis
of RMac obtained following transfer into macrophage-depleted
recipients revealed that compared with the point of transfer
(Supplementary Fig. 4d, e), the ratio of Tim4+ RM-LPM to Tim4
− Mo-LPM within this population decreased over the ensuing
8 days (Supplementary Fig. 4g) due to greater expansion of the
Tim4− fraction (Supplementary Fig. 4h). Indeed, while both
subsets were equivalently labeled with PKH26-PCL prior to
transfer (Supplementary Fig. 4f), the Tim4− fraction subsequently
lost significantly more dye (Supplementary Fig. 4i), consistent
with overall greater proliferation. Hence, heightened proliferative
capacity appears to be a feature of monocyte-derived macro-
phages, irrespective of the conditions under which these cells have
infiltrated the cavity.
Furthermore, while both MoZ10-LPM and RMZ10-LPM
displayed typical macrophage morphology, the cytoplasm of
RMZ10-LPM contained many more vacuoles (Fig. 4d) indicative
of greater phagocytic activity. Indeed, both MoZ10-LPM and Mo-
LPM had appreciably lower side-scatter characteristics than their
RM counterparts, albeit higher than SPM (Fig. 4e). Moreover,
examination of phagocytic potential in vitro using pHrodo-
labeled Escherichia coli particles revealed that Tim4+ LPM from
naïve mice and 8 weeks after inflammation were significantly
more phagocytic than the Tim4−fraction (Fig. 4f). Of note,
incubation at 37 °C for 1 h caused rapid acquisition of surface
Sema4a by Tim4+ macrophages thereby preventing analysis of
Sema4a-defined populations in this assay. Furthermore, re-
analysis of our short-term transfer experiments revealed that
only Tim4+-recipient LPM acquired PKH26-PCL dye from
donor RMac irrespective of whether recipients were naïve or
zymosan-injected (Supplementary Fig. 4j, k), suggesting uptake of
dying donor cells is restricted to Tim4+ cells. These data are also
consistent with cell death rather than emigration from the cavity
as the predominant mechanism by which excess macrophages are
cleared from the cavity33. Lastly, to test responsiveness to
challenge, RM-LPM and Mo-LPM from naïve mice and
RMZ10-LPM and MoZ10-LPM obtained 8 weeks post zymosan
injection were purified and exposed in vitro to lipopolysaccharide
(LPS) and cytokine and chemokine production assessed by
multiplex assay. The overall response of MoZ10-LPM and Mo-
LPM compared to their RM counterparts was remarkably similar;
both produced higher levels of IL-10 and somewhat more IL-1β
and GM-CSF and less CXCL10 and TNF (Fig. 4g, h), suggesting
these are common features of monocyte-derived LPM. Further-
more, direct comparison confirmed that despite some subtle
differences, Mo-LPM and MoZ10-LPM produced largely similar
quantities of cytokines and chemokines, as did RM-LPM
compared with RMZ10-LPM (Supplementary Fig. 4l, m). Hence,
together with our gene expression profiling, these data suggest
that recency-of-monocyte origin more strongly influences the
behavior of LPM than prior experience of inflammation and that
persistence of inflammatory macrophages leads to the expansion
of a normally minor subset of IL-10 producing monocyte-derived
LPM present under homeostatic conditions. Finally, we found
that purified MoZ10-LPM transferred into naïve-recipient mice
produced less TNF than transferred RMZ10-LPM upon subse-
quent injection of LPS (Fig. 4i, j), confirming these cells also
respond differently to challenge in vivo.
Fate of inflammatory macrophages is dependent on the
severity of inflammation. In the mild model of sterile peritonitis
studied so far, the initial macrophage “disappearance reaction”
and inflammatory response that occurs is relatively limited and
transient38. In contrast, injection of a 100-fold higher dose of
zymosan (1000 µg/mouse) induced an almost complete and
protracted disappearance of F4/80Hi Tim4+ LPM concurrent
with a greater and more protracted influx of monocytes and
neutrophils44 and overall increase in size of the CD11b+ mac-
rophage/monocyte compartment (Supplementary Fig. 5a).
Notably, the CD11b+ population remained exclusively F4/80Lo
MHCIIHi for at least 11 days although Tim4+ cells had begun to
re-emerge within this time (Supplementary Fig. 5b). Importantly,
analysis in tissue-protected BM chimeric mice confirmed that the
entire peritoneal macrophage pool, including Tim4+ cells, had
been replaced from the BM 3 weeks after high-dose zymosan
(Fig. 5a and Supplementary Fig. 5c). Thus, severe sterile perito-
neal inflammation is a physiological setting leading to the com-
plete ablation and replacement of resident LPM.
Hence, to understand the fate of inflammatory macrophages
after severe inflammation we purified dye-negative inflammatory
macrophages 3 days after injection of high- or low-dose zymosan
(IMacZ1000; Supplementary Fig. 5d) and transferred them into
their native inflammatory environments. Markedly fewer donor
IMacZ1000 persisted at 8 weeks in recipients of high-dose
zymosan compared with those receiving low-dose zymosan
(Fig. 5b), consistent with the greater contraction in size of the
peritoneal macrophage compartment (Supplementary Fig. 5a)
and the reported death of the majority of inflammation-elicited
macrophages that follows resolution of severe peritoneal
inflammation33,45. However, those surviving IMacZ1000 in the
high-dose environment adopted a F4/80HiGATA6+ profile by
8 weeks following severe inflammation and almost none
subsequently expressed CCR5 or FRβ (Fig. 5c–e). These results
are consistent with a more mature phenotype, again reflecting
more rapid differentiation in the absence of competition from
enduring resident macrophages. Nevertheless, a shared deficiency
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21778-0
8 NATURE COMMUNICATIONS |         (2021) 12:1770 | https://doi.org/10.1038/s41467-021-21778-0 | www.nature.com/naturecommunications
of IMac-derived cells in both high and low-dose environments
was the failure to produce CXCL13, a GATA622,23 and RXRAB26
independent feature of LPMs. Thus, these data suggest impaired
CXCL13 expression by IMac arises from long-term alterations in
the LPM niche that occurs irrespective of inflammation severity
and retinoic acid production. IMacZ1000 and IMacZ10-derived
cells also largely shared the propensity to express the intrinsic
marker of monocyte-derived LPM Sema4a (Fig. 5e), and to lack
expression of the environment-independent but time-dependent
marker VSIG4 (Fig. 5e). Surprisingly, IMacZ1000 retained high
levels of MHCII, and largely expressed the otherwise time-
dependent marker Tim4 (Fig. 5e). Furthermore, donor-derived
macrophages following severe inflammation almost perfectly
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uniform origin from inflammatory macrophages (Supplementary
Fig. 5e). In contrast, in the lower dose environment host
macrophages neither aligned with RMacZ10 nor IMacZ10 but
corresponded to a mixed population of these cells, (Fig. 5f and
Supplementary Fig. 5e) re-emphasizing that phenotype is
ontogeny-restricted in this environment. Consequently, the
LPM compartment on the whole 8 weeks after high-dose
zymosan differed markedly to that after low-dose zymosan for
each marker assessed (Supplementary Fig. 5e).
As both F4/80 and MHCII expression by IMacZ10 were rapidly
responsive to niche signals and competition with LPM after low-
dose zymosan (Fig. 1i, l), we postulated that the initially
prolonged absence of F4/80hi LPM, rapid acquisition of Tim4
expression, and persistent expression of MHCII by recruited cells
(Supplementary Fig. 5b) following severe inflammation arose
from an altered cavity environment. To test this, we adoptively
transferred 4 × 105 F4/80Hi, largely MHCIILo, resident macro-
phages from naïve mice (RMac) into recipient mice 3 days after
injection of high-dose zymosan (Fig. 5g). Eight days later
transferred cells had almost exclusively upregulated MHCII
expression and markedly downregulated expression of F4/80
(Fig. 5h, i). Moreover, transfer of RMac suppressed the rapid
acquisition of Tim4 by host cells, as indicated by a specific
decrease in number of Tim4+ host macrophages (Fig. 5i). Hence,
novel environmental cues following severe inflammation directly
drive expression of MHCII, and in conjunction with the absence
of embryonically seeded Tim4+ resident macrophages allow rapid
acquisition of Tim4 by monocyte-derived cells. Furthermore,
there appears to be a phase of at least 11 days during
severe peritonitis where the cavity does not support expression
of F4/80 that, given the dependence of F4/80 expression by
LPM on GATA6 and retinoic acid5,22,23 (Fig. 2a, b and
Supplementary Fig. 2f), suggests severe peritoneal inflammation
leads to a protracted but ultimately transient loss in retinoic acid
availability.
Inflammation leads to long-term disruption of B1 cell home-
ostasis. Although the failure to produce CXCL13 was a common
feature of IMac-derived LPM (Fig. 5e), treatment with high-dose
zymosan led to a striking reduction of CXCL13+ peritoneal
macrophages (Fig. 5j) arising from the comprehensive loss of the
incumbent CXCL13-expressing resident cells. Given the non-
redundant role of CXCL13 in maintenance of the peritoneal B1-
cell pool46, we investigated whether peritoneal inflammation led
to long-term disruption of B1 cells. Temporal analysis revealed
that while the number of CD11b+ B1 cells15 gradually increased
with age under homeostatic conditions (Fig. 5k and Supple-
mentary Fig. 6a), the degree of accumulation was slightly reduced
following mild inflammation and completely abrogated following
severe inflammation, yet neither led to absolute loss of B1 cells
over baseline levels (Fig. 5l and Supplementary Fig. 6b). Direct
comparison of numbers of B1 cells in recipient mice from
adoptive transfer experiments confirmed that severe inflamma-
tion led to substantially fewer CD11b+ peritoneal B1 cells within
the cavity than following mild inflammation (Supplementary
Fig. 6c). Furthermore, severe inflammation led to increased levels
of serum IgM against phosphorylcholine, the predominant target
of natural antibodies produced by peritoneal B1 cells46,47 and to
the appearance of anti-phosphorylcholine IgG (Fig. 5m). Hence,
sterile peritoneal inflammation leads to a state of altered home-
ostasis characterized by a failure to increase numbers of perito-
neal CD11b+ B1 cells over time but which is associated with
increased levels and class-switching of circulating natural anti-
body. Furthermore, unlike mild inflammation, severe inflamma-
tion also led to a reduction in number of naïve CD62L+ cavity
T cells at 8 weeks (Supplementary Fig. 6d, e) and a low but
detectable number of neutrophils (Supplementary Fig. 6d, f)
despite the apparent clearance of zymosan from the peritoneal
fluid (Supplementary Fig. 6g, h), suggestive of a state of persistent
ongoing low-grade peritoneal inflammation.
Discussion
Transient peritoneal inflammation has lasting consequences
for the incidence and severity of future disease40,48 but the
mechanisms underlying this effect remain largely unresolved.
Here, we demonstrate that inflammatory peritoneal macrophages
recruited following sterile inflammation persist long-term but in
an aberrant state of activation largely due to an inability to
compete with incumbent macrophages for niche signals and
inflammation-driven alterations in the peritoneal environment.
In so doing, we reveal the existence of multiple overlapping
biochemical niches that control programming of resident peri-
toneal macrophages and which are distinct from that controlling
cell survival.
Like Liu et al.37, our study suggests that the degree of repla-
cement of LPM from the bone marrow following inflammation
depends on the magnitude of initial macrophage disappearance.
Furthermore, the increased survival of inflammatory macro-
phages following transfer into macrophage-depleted recipients
provides definitive evidence that incumbent LPM impair survival
Fig. 4 Monocyte-derived LPM are functionally distinct from embryonically seeded LPM. a Tim4 and Sema4a expression by RMac, RMacZ10, and IMacZ10
8 weeks post transfer and host cells. b Proportion of RMacZ10 (blue, n= 6), IMacZ10 (orange, n= 6), and host (gray) macrophages with Sema4aLoTim4+(R1),
Sema4aHiTim4+(R2), Sema4aHiTim4− (R3), or Sema4aLoTim4− (R4) phenotype. ***p < 0.001, ****p < 0.0001, one-way ANOVA and Tukey’s multiple
comparisons test. c Ki67 expression on naïve RM-LPM and Mo-LPM (n= 5) or 8-week post zymosan RMZ10-LPM and MoZ10-LPM (n= 8). Naïve; p=0.0001
(***), Post zymosan; p=0.008(**), paired student’s t-test. d Morphological appearance of RMZ10-LPM and MoZ10-LPM 8 weeks post zymosan. Single
experiment, scale bar 20 μm. e Mean side scatter of naïve RM-LPM, Mo-LPM, SPM (n= 5) or 8 weeks post zymosan RMZ10-LPM, MoZ10-LPM, and SPMZ10
(n= 8). Naïve; both p < 0.0001(****), post zymosan: p=0.0062(**), p=0.0008(***), one-way ANOVA with Tukey’s multiple comparisons test. f Normalized
Phrodo E.coliMFI (MFI 37 °C minus MFI 4 °C) on naïve (n= 6) or 8 weeks post zymosan (n= 9) Tim4+ and Tim4− macrophages. Naïve; p=0.0048(**), Post
zymosan; p=0.0002(***), paired student’s t-test. g Analytes secreted by RM-LPM (n= 6, teal) or Mo-LPM (n= 5, red) sourced from naïve animals following
14 h LPS (1 ng/ml) treatment. Results shown as log2 fold change in mean pg/ml over mean RM-LPM. Box extends from the 25th to the 75th percentile, middle
line denotes median. Whiskers denote minima and maxima. **p < 0.001, ***p < 0.0001, repeated student’s t-test with Holm-Sidak correction. h Analytes
secreted by RMZ10-LPM (n= 8, teal) or MoZ10-LPM (n= 8, red) sourced 8 weeks post zymosan following 14 h LPS (1 ng/ml) treatment. Results shown as log2
fold change in mean pg/ml over mean RMZ10-LPM. Box extends from the 25th to the 75th percentile, middle line denotes median. Whiskers denote minima and
maxima. *p < 0.05 **p < 0.001, ***p < 0.0001, repeated student’s t-test with Holm-Sidak correction. i Experimental scheme for purification of RMZ10-LPM and
MoZ10-LPM from donor mice treated 8 weeks prior with 10 μg zymosan and transfer into naïve-recipient mice followed by injection of 5 μg LPS IP. j Proportion
of donor CD45.2+ F4/80Hi RMZ10-LPM (n= 7) and MoZ10-LPM (n= 6) 8 h post injection of LPS that express TNF. p=0.0206(*), student’s t-test. Data are
presented as mean ± standard deviation with each symbol representing an individual animal. Naïve animals were age matched to zymosan-treated (15–18-week)
animals. For (c, g), animals were 10–12-week at time of analysis. Data pooled from two independent experiments.
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of recruited cells. Hence, even without a defined physical niche,
monocyte contribution to resident macrophages within fluidic
environments appears subject to the same parameters of niche
access and availability proposed by Guilliams and Scott16.
Likewise, our data support a model whereby competition for
access to a biochemical niche plays a critical role in determining
the long-term transcriptional identity of inflammation-elicited
macrophages. Specifically, inflammation-elicited macrophages that
survived following mild inflammation exhibited striking long-term
differences to incumbent resident macrophages including high
MHCII and low GATA6 expression, yet more rapidly adopted a
GATA6Hi MHCIILo resident-like phenotype and transcriptome
following transfer into naïve macrophage-depleted mice. The
failure of inflammation-elicited macrophages to down-regulate
MHCII expression following transfer into intact naïve mice
confirms this feature arises from competition with incumbent
resident macrophages for signals that regulate MHCII expression.
Consistent with this, inflammation-elicited macrophages rapidly
downregulated MHCII in vitro in response to RA-independent
omental factors. Similarly, the GATA6Lo phenotype of
inflammation-elicited macrophages following mild inflammation
likely arises due to competition with enduring resident macro-
phages for retinoic acid, since more rapid acquisition of a
GATA6Hi phenotype occurred following severe inflammation
concurrent with the ablation of resident macrophages. Critically,

























































































































































































































































































































































































































NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21778-0 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1770 | https://doi.org/10.1038/s41467-021-21778-0 |www.nature.com/naturecommunications 11
seemingly regulated by competition, suggesting that with time
these cells receive sufficient cues to acquire a mature resident
phenotype.
Several features of inflammation-elicited macrophages
appeared regulated by changes in the cavity micro-environment
post inflammation. For example, severe inflammation led to
sustained expression of MHCII by inflammation-elicited macro-
phages despite natural ablation of competing resident cells. Fur-
thermore, the severely inflamed environment triggered MHCII
expression by adoptively transferred resident LPM that would
otherwise remain largely MHCII− in a non-inflamed or mild
inflammation setting. Hence, it seems likely severe inflammation
triggers release of novel signals stimulatory for MHCII.
A small number of genes remained differentially expressed in
inflammation-elicited macrophages following transfer into
macrophage-depleted mice, supporting the notion that develop-
mental origin influences macrophage identity49. These included
features reprogrammed over time (e.g., TIM4, VSIG4, CD209b),
and permanent “legacy” features of monocyte-derived cells (e.g.,
Sema4a, CD62L). The processes regulating these traits remains
unclear49. However, the rapid acquisition of Tim4 expression by
inflammation-elicited LPM following severe inflammation and
the inhibition of this by transfer of Tim4+ resident macrophages
provides proof-of-principle that seemingly origin-related time-
dependent features of resident macrophages can be rapidly
reprogrammed by appropriate niche signals.
While the panel of genes assessed here was relatively limited,
our findings that gene expression is largely dictated by competi-
tion with resident cells or the post-inflammatory environment are
likely to hold true on the transcriptome as a whole. For example,
the overlap between environment-dependent genes and GATA6
regulated genes5,22,23 suggests lower GATA6 expression by
inflammation-elicited macrophages controls a significant pro-
portion of their unique transcriptional profile. Similarly, the
retarded expression of GATA6 by monocyte-derived LPM mac-
rophages recruited during homeostasis also likely underlies a
significant degree of the distinct transcriptional clustering of these
cells. Critically, these data reveal that GATA6 expression does not
act binarily but rather the level of expression has a critical role in
determining LPM identity, as predicted for transcription factors
with many competing target sites50.
One of our most intriguing findings was the difference in
proliferative activity of resident and monocyte-derived LPM, with
only the latter exhibiting the capacity to overtly expand following
transfer into macrophage-depleted mice. Notably, GATA6
directly regulates proliferation of LPM23, suggesting this disparity
may relate to differences in GATA6 expression. However, as
treatment with exogenous CSF1 or IL-4 stimulates recently
recruited and incumbent resident macrophages to proliferate to
equivalently high degrees21,37,51, the poor expansion of incum-
bent resident macrophages within the macrophage-deplete
environment cannot be due to an intrinsic inability to pro-
liferate. Rather, GATA6-deficient macrophages have an enhanced
ability to interact with mesothelium5, suggesting monocyte-
derived LPM may have a greater ability to utilize the membrane-
bound CSF1 produced by these cells52.
Despite differentiating under inflamed conditions, persistent
inflammation-elicited LPM bore striking similarities to monocyte-
derived LPM present under non-inflamed conditions. As well as
gene expression and proliferative activity, monocyte-derived LPM
exhibited a largely comparable response to LPS irrespective of
condition of differentiation, most notably characterized by
increased production of IL-10 compared to embryonically seeded
LPM. Other than IL-1β, the profile of cytokine production by
monocyte-derived LPM was the opposite reported for GATA6-
deficient LPM53, suggesting other factors control their differential
response to LPS. Hence, mild peritonitis does not lead to the
existence of a unique subset of LPM but rather the expansion of a
subset present in homeostasis. As we have previously shown that
the abundance of Tim4− monocyte-derived LPM gradually
increases with age21, it would appear that mild inflammation
accelerates a process normally associated with aging.
Our data also predict that inflammation-elicited LPM fail to
express Cxcl13 due to inflammation-induced loss of requisite
niche signals. Notably, Cxcl13 expression by LPM is sustained
in vitro without addition of niche factors43, potentially explaining
why CXCL13 expression remains intact in incumbent LPM fol-
lowing mild inflammation. Hence, unlike the reversible program
of gene expression controlled by GATA6 that is lost in the
absence of RA43, niche signals required to induce expression of
CXCL13 in newly recruited macrophages may not be needed to
maintain expression in resident cells.
Cxcl13-deficient mice are profoundly deficient in peritoneal
B1 cells46 yet CXCL13 is not required for retention of B1 cells in
the cavity54. We found the extent of inflammation and conse-
quently the ratio of CXCL13-producing resident macrophages to
monocyte-derived CXCL13- LPM in the cavity correlates with a
failure to accumulate peritoneal B1 cell with age. As no other
peritoneal lavage cells produce CXCL1315,46, our data suggest
CXCL13 production by peritoneal macrophages is required for
Fig. 5 Ontogeny does not control monocyte phenotype after severe peritonitis and leads to impaired B1 cell expansion. a Normalized chimerism of
Tim4+ macrophages in tissue-protected BM chimeric mice left naïve or treated with 10 μg or 1000 μg zymosan 17 days prior (n= 3/group). **p < 0.01,
one-way ANOVA and Tukey’s multiple comparisons test. b Engraftment efficiency of RMacZ10 (n= 6), IMacZ10 (n= 5), and IMacZ1000 (n= 6), after
transfer into the mirroring recipients. p= 0.005(**), p= 0.00038(***), one-way ANOVA and Tukey’s multiple comparisons test. c Expression of F4/80
and MHCII on indicated populations 8 weeks post after transfer. d GATA6 MFI of donor RMacZ10, IMacZ10 and IMacZ10 after transfer into native recipients
(n= 3, 2, 3). e Marker expression by CD102+ or F4/80+ donor RMacZ10 (blue), IMacZ10 (orange), and IMacZ1000 (purple) 8 weeks after transfer into
mirroring recipients (n= 6, 5, 6). *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA and Dunnet’s multiple comparisons test for each marker, followed by
Bonferroni adjustment. f Principal component analysis based on all markers assessed in e. g Scheme for transfer of F4/80Hi MHCIILo naïve resident
macrophages (RMac) into mice injected 3 days prior with 1000 μg zymosan. h F4/80, Tim4, and MHCII expression on RMac and host myeloid cells
8 days post transfer. i Proportion of RMac that express MHCII and high levels of F4/80 before transfer and 8 days post transfer (n= 5; left). Number
of host Tim4+ or Tim4- macrophages 8 days post transfer (n= 5). In order: p < 0.0001 (****), p < 0.0001 (****), p= 0.021 (*), student’s t-test. j Number of
CXCL13+ host macrophages 8 weeks after 10 μg (n= 11) or 1000 μg zymosan (n= 6) treatment. p= 0.0020 (**), student’s t-test. k Number of peritoneal
B1 cells in naïve female mice at indicated age in weeks (n= 5/timepoint). p= 0.00047(***), one-way ANOVA and Tukey’s multiple comparisons test.
l Number of peritoneal CD11b+ B1 cells at indicated timepoints in naïve mice (black; n= 5, 6, 10) or mice treated with 10 μg (gray; n= 6, 11, 20) or 1000 μg
zymosan (white; n= 3, 3, 4). *p < 0.05, ***p < 0.001, ****p < 0.0001, two-way ANOVA and post hoc Tukey test. m Serum anti-phosphorylcholine IgM and
IgG in naïve mice (n= 6), or mice treated with 10 μg (n= 16) or 1000 μg (n= 2) zymosan 8 weeks prior. Data are presented as mean ± standard deviation
with each symbol representing an individual animal. Data were pooled from at least two independent experiments except high-dose treatment (l,m), which
is a single experiment. Host cells represented by squares or circles are recipients of RMacZ10 or IMacZ10, respectively.
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continued recruitment of B1 cells from the circulation. Notably,
replacement of peritoneal LPM by monocytes and concurrent
failure to expand peritoneal B1 cells also occurs following
abdominal surgery15. Hence, long-term dysregulation of B1 cells
is likely a general feature of peritoneal inflammation. Sterile
peritoneal inflammation also led to elevated circulating natural
antibody. Whereas splenic and bone marrow B1 cells sponta-
neously secrete high levels of natural IgM, those in the cavities do
not55. Furthermore, levels of serum anti-PC IgM gradually drop
with age56. Hence, we speculate that the failure to accumulate
B1 cells in the peritoneal cavity may allow their re-entry into
tissues permissive for antibody secretion such as fat associated
lymphoid clusters57.
In addition to perturbed homeostasis of B1-cells, high-dose
zymosan treatment led to a significant long-term elevation in
number of peritoneal neutrophils and decrease in number of
naïve CD62L+ peritoneal T cells, suggesting persistent low-grade
peritoneal inflammation. Whether this represents a permanent
alteration in tissue homeostasis and if so whether this arises from
innate or adaptive immune memory58 or dysregulation of normal
feedback loops between tissue T cells and macrophages59 remains
unclear, but notably, loss of peritoneal CD62L+ T-cells has been
implicated in low-grade peritoneal inflammation and induction
of MHCII-expression on peritoneal macrophages27. Furthermore,
we cannot at present exclude the possibility that these alterations
in immune cell homeostasis are driven by the continued presence
of an undetected reservoir of zymosan.
Our study highlights how varying degrees of inflammation
alter the peritoneal macrophage compartment long-term and
consequently reshape peritoneal homeostasis, and implicates
competition for niche signals, time-of-residency and alterations
in niche as principal determinants of these phenomena. These
findings have broad importance for our understanding of
plasticity within the mononuclear phagocyte compartment.
Furthermore, understanding the consequences of inflammation
in the serous cavities has major implications for pathologies in
which serous cavity macrophages play key roles, including
endometriosis60, adhesions61, and repair and scarring of visc-
eral organs20,62 and the myriad of diseases influenced by nat-
ural antibody63.
Methods
Mice and reagents. C57BL/6JCrl and congenic CD45.1+CD45.2+ mice (B6.SJL-
PtprcaPep3b/BoyJ × C57BL/6JCrl) were bred and maintained in specific pathogen-
free facilities at the University of Edinburgh, UK. In some experiments, C57BL/
6JCrl mice were purchased from Charles River, UK. Mice were sex matched in all
experiments and used at 6–10 weeks of age at the start of the experiment. All
animal experiments were performed under license by the UK Home Office and
received ethical approval from the University of Edinburgh Animal Welfare and
Ethical Review Body. All animal experiments were performed in accordance with
the ethical regulations for animal testing and research as set out by the UK Animals
(Scientific Procedures) Act of 1986. Details of reagents and antibodies used can be
found in Supplementary Tables 1 and 2.
Sterile peritoneal inflammation. To elicit sterile peritoneal inflammation, mice
were injected with 10 or 1000 µg of zymosan A (Sigma-Aldrich) suspended in
200 µl Dulbecco’s PBS (Invitrogen), dPBS or left naïve as indicated. In some
experiments, mice were injected intraperitoneally with 250 µl of 700 nm PKH26-
PCL in suspended in Diluent B (Sigma) 24 h prior to zymosan. In some experi-
ments, mice were injected intraperitoneally with 0.0625 mg Clodronate liposomes
(Liposoma) suspended in 250 µl dPBS (Gibco). To elicit LPS-induced inflammation
mice were injected intraperitoneally with 5 µg of LPS (O111:B4, Sigma-Aldrich)
suspended in 200 µl dPBS.
All trans retinoic acid administration. Stock ATRA was prepared in DMSO
(40 mg/ml; both Sigma-Aldrich). On the day of injection a working solution was
prepared by diluting ATRA stock in sterile corn oil (Sigma-Aldrich) to a con-
centration of 8.33 µg/µl. Mice received IP injection with 30 µl of stock solution IP at
indicated timepoints, equating to 250 µg per injection.
Tissue-protected BM chimeric mice. Eight week-old female C57BL/6J
CD45.1+CD45.2+ or CD45.2+ C57BL/6J mice were exposed to a single dose of
9.5 Gy γ-irradiation under anesthetic, with all but the hind legs of the animals
protected by a 2-inch lead shield. Animals were subsequently given 2–5 × 106 BM
cells from female congenic CD45.2+ C57BL/6J or C57BL/6J CD45.1+CD45.2+
animals, respectively, by i.v. injection and then left for 8 weeks, or in one experi-
ment for 26 weeks due to the COVID-19-pandemic, before injection of zymosan.
Cell isolation and flow cytometry. Mice were sacrificed by exposure to rising
levels of CO2. The peritoneal cavity was lavaged with a total of 9 ml wash solution
(dPBS containing 2 mM EDTA,1 mM HEPES) or 9 ml culture solution (RPMI
containing 1 mM HEPES) if cells were used for subsequent cell culture experi-
ments. In some experiments, blood was then taken from the inferior vena cava or
the carotid artery and serum isolated using Microtainer SST tubes (BD). Serum was
frozen at −80 °C before analysis by ELISA. For chimeric mice, blood samples were
also taken on the day of necropsy by cardiac puncture or by cutting the carotid
artery. Equal cell numbers where incubated at room temperature for 10 min with
zombie aqua viability dye (BioLegend), followed by 10-min incubation on ice with
blocking buffer containing 10% mouse serum with 0.25 µg/ml anti CD16/CD32
(BioLegend). Cells where incubated with indicated antibodies (Supplementary
Table 2) on ice for 30 min. Cells where washed with FACS buffer (2 mM EDTA/
0.5%BSA in PBS) and if applicable stained with streptavidin conjugated or sec-
ondary antibody. For intracellular staining, cells where fixed/ permeabilized using
the Foxp3 staining buffer (eBioscience) according to the manufacturers protocol.
For intracellular cytokine staining 1E6 peritoneal cells were incubated for 4.5 h at
37 °C in 200 μl sterile RPMI containing Brefeldin A and Monensin (both 1:1000) in
cell repellent 96-well plates (Greiner Bio-One) after which cells were washed once
and stained on ice for extracellular and intracellular as described with one addi-
tional Fc blocking step (10 min on ice) after fixation. Samples were acquired using
FACS LSRFortessa (BD) and analyzed using Flowjo (Version 10.4.1,Treestar). For
analysis doublets (on the basis of Forward scatter area vs height) and dead cells
(ZombieAqua positive) were excluded. For cell sorting, cells were stained using the
same protocol scaled accordingly DAPI was used as viability dye to ensure real time
viability detection. For adoptive transfer studies and cell culture studies, cells were
sorted using a FACSFusion of FACSAria sorting system with a 100 µm sort nozzle.
Cells sorted for RNA extraction were sorted using a 70 µm nozzle.
Adoptive transfer of macrophages. Cells were kept on ice at all time and all steps
were carried out in a laminar flow hood using sterile reagents. Cells were collected and
stained as described above and were sorted using flow cytometry into the indicated
populations. Post sort cells were pelleted (300 × g, 5 min at 4 °C), resuspended in
200 µl of dPBS and counted by Casy Counter (Scharfe). For short-term and long-term
studies 1 × 105 and 1 × 105 cells of the indicated populations were transferred
respectively. For transfer of RMac into high-dose zymosan-treated recipients, 4 × 105
cells were used. To study responsiveness to LPS in vivo, 2.5 × 105 cells of each of the
indicated populations was transferred. If required, purified populations from multiple
donor mice were pooled. For each experiment, purified cells were suspended in 200 µl
of dPBS and injected intraperitoneally into recipients. Survival of donor cells
throughout the manuscript is presented as engraftment efficiency, which is the No. of
donor cells transferred/No. of donor cells retrieved*100.
NanoString assay. For each of the indicated donor populations 5000 cells of
interest were sorted into 2 µl of RLT (QIAGEN). Immediately after cells were
centrifuged at maximum speed 15 s, vortexed for 10 s and again centrifuged at
maximum speed 15 s. Cells where stored at −80 °C until analysis using the
nCounter Myeloid innate immunity panel (NanoString) according to the manu-
facturer’s instructions. Data was analyzed using the nSolver advanced analysis
package. Differential gene expression was determined by pairwise comparison of
IMacZ10 and RMacZ10 to RMac. Benjamini Hochberg adjusted p-value < 0.05 were
considered differentially expressed. Figures were generated using R packages
GGplot2, Pheatmap, EnhancedVolcano and GOplot.
Gene expression ranking analysis. Following NanoString analysis, the normal-
ized messenger RNA gene-counts for each donor population following transfer into
mirroring or clodronate-depleted recipients were collected. For each sample all
detected genes were ordered on the basis of their expression levels. Each gene was
assigned a percentile rank based on the rank in the ordered gene list. Then a delta
gene rank percentile was calculated for each donor population (Percentile rank in
native environment—Percentile rank in depleted environment) and plotted. This
analysis was adapted from Galatro et al.64.
Gene-set enrichment analysis. Gene set of GATA6-regulated genes was obtained
by analyzing GSE56711, GSE37448, and GSE47049 using the GEO2R. Genes were
considered GATA6 regulated if they were differentially expressed (p-adj < 0.05) in
2 out of 3 published GATA6KO datasets5,22,23. The gene list was split into
GATA6KO up and downregulated gene sets. GSEA was carried out using GSEA
desktop 4.1 (Broad Institute). RNA levels of genes in RMacZ10 and IMacZ10 were
analyzed using default settings and 10.000 geneset permutations. A gene set of
RXRAB-regulated genes was obtained by analyzing GSE129095 using the GEO2R
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tool. Genes were GATA6-independently, RXRAB-regulated if they were differen-
tially expressed (p-adj < 0.05) in GSE129095 but were not regulated by GATA6.
The resulting gene list was split into RXRABKO up and downregulated gene sets for
GSEA analysis.
Omentum factors production and treatment. Omentum factors were generated
by culturing the omentum from naïve mice in 1 ml of macrophage serum-free
media (GIBCO) for 5 days as described5 after which medium was collected, cen-
trifuged at 300 × g and the supernatant collected and diluted in 1:2 in media.
Peritoneal cells were collected 11 days post low-dose zymosan were collected as
described under sterile conditions and 5 × 105 plated and incubated for 2 h at 37 °C
in cell culture medium (RPMI, 10%FCS, 1% L-Glutamine and 1% penicillin/
streptomycin supplemented with 20 ng/ml CSF1) after which medium was aspi-
rated and cells were incubated in 250 μl cell culture medium with 250 μl Omentum
factors or macrophage serum-free media with ATRA (Sigma, 1 μm) or without for
24 h. Then, medium was removed and plate was incubated with 5 mM EDTA in
ice-cold PBS for 10 min on ice to collect cells. Wells were repeatedly washed with
ice-cold 5 mM EDTA PBS and wells were inspected using a microscope to confirm
negligible adherent cells remained. Cells were quantified and prepared for flow
cytometry as described.
Cytokine production assay. Cells were kept on ice at all time and all steps were
carried out using sterile reagents in a laminar flow hood using the sort protocol
described. For each population of interest 1 × 103 cells per condition were sorted
into 75 µl sort medium (folic acid-deficient RPMI containing 20% FCS (low
endotoxin), 2% L-Glutamine and 2% penicillin/streptomycin). Cells were cen-
trifuged at 100 × g at 4 degrees for 5 min. The total mixture was then transferred
into a 96-well plate incubated at 37 °C for 2 h. Media was gently aspirated and cells
were resuspended in 75 μl cell culture medium (folic acid-deficient RPMI supple-
mented with 1 μg/ml Folic Acid (Sigma-Aldrich), 10% FCS (low endotoxin), 1% L-
glutamine and 1% penicillin/streptomycin). Where indicated cells received a final
concentration of LPS of 1 ng/ml (O11:B4, Sigma-Aldrich) in cell culture medium or
equivalent amount of dPBS. Cells were incubated for 14 h and supernatant was
collected and analyzed for cytokine release using the Legendplex Mouse Anti-Virus
or Mouse Inflammation panel according to the manufacturers protocol. Data was
acquired using an Attune flow cytometer and analyzed using the Legendplex
analysis software.
Phrodo phagocytosis assay. Cells were collected and 2 × 106 cells/sample were
stained as described. Each sample was washed twice with ice-cold RPMI and was
split into two tubes each and left on ice for 10 min. Then to each tube 10 μl of
Phrodo E. coli particles was added and for each sample one tube was incubated at
37 °C and one at 4 °C for 1 h. All samples were placed on ice and washed once
using 300 μl Buffer C and were then resuspended in 300 μl Buffer C. Cells were
analyzed directly after finishing the protocol. Data is presented as normalized
Phrodo mean fluorescence intensity (MFI 37 °C minus MFI 4 °C).
Enzyme-linked immunosorbant assays. Ninety-six-well flat-bottom high-binding
polystyrene plates (Corning) were coated with 50 μl of 2 μg/ml phosphorylcholine
conjugated to BSA (PC-BSA; 2B Scientific) diluted in PBS at 4 oC overnight. Plates
were then blocked with 100 μl of blocking buffer (1% Casein in PBS; VWR) for 1.5
h at room temperature, before serum samples were added at 1:100 dilution in 50 μl
blocking buffer and incubated for 2 h at room temperature. Wells without antigen
were used as blank controls for each sample to measure non-specific antibody
binding. Plates were then incubated with 1:5000 HRP-conjugated anti-mouse IgG
(Abcam) or 1:2000 anti-mouse IgM (Southern Biotech) in blocking buffer for 1 h at
room temperature before addition of 3,3′,5,5′-tetramethylbenzidine (TMB) (Ser-
acare). After 10 min the reaction was stopped with 0.16M sulfuric acid solution
and the OD450 value measured. Values for blank controls were then subtracted for
each sample to quantify antigen-specific antibody levels. Plates were washed twice
with 0.1% Tween20 (Sigma-Aldrich) in PBS between all steps except before
addition of TMB, when they were washed five times.
Statistics. Statistics were performed using Prism 7/8 (GraphPad Software). The
statistical test used in each experiment is detailed in the relevant figure legend. For
all t-tests performed in this manuscript the two-tailed p-value is presented and
interpreted.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Nanostring data that support the findings of this study have been deposited in the Gene
Expression Omnibus under the accession code GSE165036. Previously published publicly
available datasets analyzed in this study are available in Gene Expression Omnibus under
the accession codes GSE56711, GSE37448, GSE47049, and GSE129095. Source data are
provided with this paper. All other data that support the findings of this study are
available from the corresponding author upon reasonable request. Source data are
provided with this paper.
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